Precede Biosciences

Breaking Barriers in Precision Medicine

Precede Biosciences was founded in 2021, is headquartered in Boston, United States, lists 11–50 employees, and has $63.5M in recorded funding across 1 round.

Headquarters
Boston
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$63.5M
Last Round
$63.5M Series BJan 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Precede Biosciences has developed a first-in-class liquid biopsy platform that profiles circulating chromatin and the DNA methylome from just 1mL of plasma. The platform provides genome-wide insight into gene promoters, enhancers, and methylation patterns to reveal disease-defining transcriptional biology. The company partners with drug developers and academic researchers to accelerate precision-medicine development and create blood-based clinical tests as alternatives to invasive tissue biopsies.

Summary

Precede Biosciences is a Biotech company based in Boston, United States, founded in 2021. It lists 11–50 employees. It has raised $63.5M in total across 1 round, most recently a $63.5M Series B round in Jan 2026. Investors include Labcorp Venture Fund, UPMC Enterprises and Mirae Asset Capital Life Science.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2026
$63.5M

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Precede Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/precede-biosciences"><img src="https://indexed.vc/api/badge/company/precede-biosciences" alt="Precede Biosciences on Indexed.vc" width="260" height="76" /></a>